FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly toxicology, and may be used for body protection against mutagenic action of chemical genotoxicants. That is ensured by introducing Ubiquinone Coenzyme Q10 0.003-0.009 ml per 100 g of live weight wit underlying heavy metal for 3-7 days.
EFFECT: method allows providing a protective effect in action of genotoxicants due to regeneration of the active form of the enzymatic system Ubiquinone Coenzyme Q10 and restoration of activity of vitamin E with maintaining biochemical process balance in cells.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ANTOMUTAGENIC IMPACT ON ORGANISM IN EXPERIMENT | 2010 |
|
RU2440135C1 |
| DIAGNOSTIC TECHNIQUE AND METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN VASCULAR COMPLICATIONS OF ALLOXAN DIABETES IN EXPERIMENT | 2010 |
|
RU2455702C1 |
| METHOD OF PREPARING ANTIMUTAGENIC PRODUCT | 2014 |
|
RU2590976C2 |
| METHOD FOR PREVENTION AND CORRECTION OF CYTOGENETIC DISORDER | 2012 |
|
RU2504392C1 |
| COMPOSITION FOR BODY MASS CONTROL AND HUMAN BODY FUNCTIONAL STATE MAINTENANCE | 2016 |
|
RU2619770C1 |
| METHOD OF CORRECTING MENSTRUAL IRREGULARITIES IN WOMEN WITH METABOLIC SYNDROME | 2022 |
|
RU2813333C1 |
| PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
| METHOD FOR CORRECTION OF OXIDATIVE STRESS AND NO PRODUCING ENDOTHELIAL DYSFUNCTION ACCOMPANYING VASCULAR COMPLICATIONS OF DIABETES MELLITUS IN EXPERIMENT | 2013 |
|
RU2521279C1 |
| ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
| METHOD FOR CORRECTION OF DISTURBED NEUROPSYCHIC STATE IN CHILDREN WITH REACTIVE ASTHENIC SYNDROME | 2023 |
|
RU2815894C2 |
